THE SKIN CANCER RESEARCH FUND
SCaRF aims to promote research into the causes, prevention and treatment of skin cancer generally, and malignant melanoma in particular. It aims to publish the results of such research and thus to help cut significantly the number of new cases of skin cancer each year in the UK. As a result to significantly cut the number of deaths from the disease.
Objects
RESEARCH INTO THE CAUSES TREATMENT AND PREVENTION OF SKIN CANCER AND ASSOCIATED KINDS OF DISEASE AND PUBLICATION OF THE USEFUL RESULTS OF SUCH RESEARCH.
Financial health, per its FY2025 accounts
The accounts state that the charity delivered a deficit of £1,907 for the year ended 31 March 2025, reducing its unrestricted funds to £546,062. The trustees report that the charity has sufficient resources to continue its operations, with a reserves policy aimed at covering committed grants and two years of administrative costs. There are no disclosed material uncertainties or risks to the charity's ability to continue as a going concern.
What the accounts disclose
“Governance and support expense was 24.8% of total income” — page 6
“The minimum level of reserves will be set at the sum of all grants already promised or committed, plus two years’ administrative costs. Based on current figures, this amounts to £53,000.” — page 9
Policies the charity declares
- Bullying and harassment policy and procedures
- Complaints policy and procedures
- Financial reserves policy and procedures
- Internal charity financial controls policy and procedures
- Internal risk management policy and procedures
- Investment
- Risk management
- Safeguarding policy and procedures
- Social media policy and procedures
- Trustee conflicts of interest policy and procedures
- Trustee expenses policy and procedures
From the charity’s annual return (Part A, self-declared)
Self-declared on the annual return for the financial year ending 31/03/2025
- Grant-making is its main activity
Self-declared on the annual return for the financial year ending 31/03/2024
- Grant-making is its main activity
Annual return filing dates (Charity Commission record)
Of its last 5 annual returns with a recorded received date, 4 were received after the due date: year ending 31/03/2025 (received 06/02/2026, 6 days after the 31/01/2026 due date); year ending 31/03/2023 (received 23/05/2024, 113 days after the 31/01/2024 due date); year ending 31/03/2022 (received 09/02/2023, 9 days after the 31/01/2023 due date); year ending 31/03/2021 (received 02/02/2022, 2 days after the 31/01/2022 due date).
Trustees
- Jonathon Pleatchair
- AMANDA McAUSLAND
- ANDREW JAMES WILKINSON
- Benjamin McGinn
- CLAIRE LANFEAR
- Dean Fuidge
- Dr Charankumal Thandi
- Dr SEONAID STIRLING
- SEGIO SANJAY SAMPAT
- SUSAN HENDRICKSON
Income and spending
| Financial year end | Income | Spending |
|---|---|---|
| 31/03/2025 | £39k | £41k |
| 31/03/2024 | £42k | £17k |
| 31/03/2023 | £345k | £56k |
| 31/03/2022 | £18k | £9k |
| 31/03/2021 | £12k | £19k |
Common questions
Is THE SKIN CANCER RESEARCH FUND financially healthy?
Per its FY2025 accounts: The accounts state that the charity delivered a deficit of £1,907 for the year ended 31 March 2025, reducing its unrestricted funds to £546,062. The trustees report that the charity has sufficient resources to continue its operations, with a reserves policy aimed at covering committed grants and two years of administrative costs. There are no disclosed material uncertainties or risks to the charity's ability to continue as a going concern. Its FY2025 accounts were independently examined.
Who funds THE SKIN CANCER RESEARCH FUND?
Funders whose own accounts filings name THE SKIN CANCER RESEARCH FUND as a grant recipient include MILLS AND REEVE CHARITABLE TRUST.
Known funders
| Funder | Year | Amount | Purpose (as stated by the funder) |
|---|---|---|---|
| MILLS AND REEVE CHARITABLE TRUST | FY2025 | £5k |
Funders of similar charities
| Funder | Similar charities funded | Amount to them |
|---|---|---|
| THE WATCHES OF SWITZERLAND GROUP FOUNDATION | 1 | £50k |
| THE ALICE ELLEN COOPER-DEAN CHARITABLE FOUNDATION | 1 | £45k |
| BONE CANCER RESEARCH TRUST | 1 | £43k |
| THE RANDAL CHARITABLE FOUNDATION | 1 | £41k |
| THE EMMANUEL KAYE FOUNDATION | 1 | £35k |
| ROBERT LUFF FOUNDATION LIMITED | 1 | £30k |
| THE LENNOX HANNAY CHARITABLE TRUST | 1 | £25k |
| TOM AND SHEILA SPRINGER CHARITY | 1 | £24k |
Charities like this
- Melanoma Fund
- MELANOMA-ME FOUNDATION
- SCLERODERMA & RAYNAUD'S UK
- Melanoma UK
- THE KAREN CLIFFORD SKIN CANCER CHARITY
- Melanoma Focus
Side by side with its peers
| Charity | Income | Top pay band | Staff >£60k | Reserves vs policy | Fundraising cost | Going concern |
|---|---|---|---|---|---|---|
| THE SKIN CANCER RESEARCH FUND | £39k | — | 0 | unclear | 24.8% | no doubt |
| Melanoma Fund | £79k | — | 0 | unclear | — | no doubt |
| MELANOMA-ME FOUNDATION | £161k | — | 0 | above | — | no doubt |
| SCLERODERMA & RAYNAUD'S UK | £433k | — | — | unclear | — | no doubt |
| Melanoma UK | £212k | — | 0 | above | 2.3% | no doubt |
| THE KAREN CLIFFORD SKIN CANCER CHARITY | £198k | — | 0 | above | — | no doubt |